Netherlands

Aspen Acquires Merck’s Dutch API Plant for $1B

Aspen Acquires Merck’s Dutch API Plant for $1B

By Zachary Brennan

The Aspen Group, a generic pharmaceutical company, is moving further into the manufacturing business with the purchase of Merck’s API manufacturing sites in the Netherlands and Iowa.